An adaptive seamless phase II/III clinical trial design incorporating short-term endpoint information

An adaptive seamless phase II/III clinical trial design incorporating short-term endpoint information

Bibliographic Details
Main Author:	Stallard Nigel
Format:	Article
Language:	English
Published:	BMC 2011-12-01
Series:	Trials

Similar Items

An Adaptive Seamless Phase II/III Design for Binary Endpoints in Clinical Trials
by: Yuan, Ming-Jun, et al.
Published: (2012)

An Adaptive Seamless Phase II/III Design in Drug Development for Binary Endpoints
by: Chang, Min-Chi, et al.
Published: (2010)

An Alternative Phase II/III Design in Clinical Trials for Continuous Endpoint
by: Liu, Chia-Pei, et al.
Published: (2010)

Seamless phase IIa/IIb adaptive design with the same primary endpoint for proof of concept and dose finding
by: Jiacheng Yuan, et al.
Published: (2018-09-01)

Dose selection in seamless phase II/III clinical trials based on efficacy and toxicity
by: Kimani, Peter Kung'u
Published: (2009)

The importance of planning for a seamless transition in an adaptive phase II randomised trial
by: Marshall Andrea, et al.
Published: (2011-12-01)

The Limb-Leaf Design: A New Way to Explore the Dose Response Curve in Adaptive Seamless Phase II/III Trials
by: Spivack, John Henry
Published: (2011)

A Phase II/III Adaptive Design for Evaluation of Drugs Efficacy Based on Continuous Endpoints
by: Wong-Shian Huang, et al.
Published: (2008)

Informative noncompliance in endpoint trials
by: Iglewicz Boris, et al.
Published: (2004-07-01)

Curtailed two-stage designs with binary endpoint in phase II clinical trials
by: Chia-min Chen, et al.
Published: (2009)

Bayesian Two-Stage Designs for Phase II Clinical Trials with Continuous Endpoints
by: Chen, Szu-Hsuan, et al.
Published: (2013)

An adaptive two-arm clinical trial using early endpoints to inform decision making: design for a study of sub-acromial spacers for repair of rotator cuff tendon tears
by: Nick Parsons, et al.
Published: (2019-12-01)

A Two-Stage Design for Stratified Phase II Clinical Trials with Continuous Endpoints
by: Zai-Jyun, Chen, et al.
Published: (2013)

A PREDICTIVE PROBABILITY INTERIM DESIGN FOR PHASE II CLINICAL TRIALS WITH CONTINUOUS ENDPOINTS
by: Liu, Meng
Published: (2017)

On Two-stage Seamless Adaptive Design in Clinical Trials
by: Shein-Chung Chow, et al.
Published: (2008-12-01)

Using Bayesian adaptive designs to improve phase III trials: a respiratory care example
by: Elizabeth G. Ryan, et al.
Published: (2019-05-01)

Curtailed Designs for Comparing Two Groups of Univariate Binary Endpoint in Phase II Clinical Trials
by: Yeh-HsinHuang, et al.
Published: (2012)

A novel Bayesian seamless phase I/II design.
by: Haitao Pan, et al.
Published: (2013-01-01)

Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological Review.
by: Miranta Antoniou, et al.
Published: (2016-01-01)

A Bayesian dose-finding procedure applied to a seamless phase I/II trial in rheumatoid arthritis
by: Whitehead Anne, et al.
Published: (2011-12-01)

Correction: A Novel Bayesian Seamless Phase I/II Design
by: Haitao Pan, et al.
Published: (2013-01-01)

Correction: A Novel Bayesian Seamless Phase I/II Design.
by: Haitao Pan, et al.
Published: (2013-01-01)

Electrocardiogram in Friedreich's ataxia: A short‐term surrogate endpoint for treatment efficacy
by: Sandra Mastroianno, et al.
Published: (2021-07-01)

A two-stage design for phase II trials with time-to-event endpoint using restricted follow-up
by: Lisa Belin, et al.
Published: (2017-12-01)

Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review
by: Miranta Antoniou, et al.
Published: (2017-01-01)

Bayesian group sequential designs for phase III emergency medicine trials: a case study using the PARAMEDIC2 trial
by: Elizabeth G. Ryan, et al.
Published: (2020-01-01)

Defining information fractions in group sequential clinical trials with multiple endpoints
by: Tu Xu, et al.
Published: (2018-06-01)

Value of Adaptive Trials and Surrogate Endpoints for Clinical Decision-Making in Rare Cancers
by: Andriy Krendyukov, et al.
Published: (2021-03-01)

The analysis of multiple endpoints in clinical trials
by: James, Susan Elizabeth
Published: (1993)

Imputation of a true endpoint from a surrogate: application to a cluster randomized controlled trial with partial information on the true endpoint
by: Duffy Stephen W, et al.
Published: (2003-09-01)

Trial design and analysis of endpoints in HIV vaccine trials
by: Richert, Laura
Published: (2013)

Adaptive Randomization for Multiarm Survival Clinical Trials Using Short-Term Response Information
by: TU,JUI-CHUAN, et al.
Published: (2019)

A systematic review of endpoint definitions in late phase pulmonary tuberculosis therapeutic trials
by: N. K. Hills, et al.
Published: (2021-08-01)

Validity of cerebrospinal fluid biomarkers as endpoints in early-phase clinical trials for Alzheimer disease
by: Zhou, Bin
Published: (2010)

Seamless superiority/non-inferiority clinical trials
by: Gurary, Ellen
Published: (2019)

Understanding the Use of Composite Endpoints in Clinical Trials
by: C. Eric McCoy
Published: (2018-06-01)

Endpoints in T0-Quasimetric Spaces: Part II
by: Collins Amburo Agyingi, et al.
Published: (2013-01-01)

Health-related quality of life as an endpoint in oncology phase I trials: a systematic review
by: Frédéric Fiteni, et al.
Published: (2019-04-01)

Phase II Trials in Drug Development and Adaptive Trial Design
by: Gail A. Van Norman, MD
Published: (2019-06-01)

Efficient confidence limits for adaptive one-arm two-stage clinical trials with binary endpoints
by: Guogen Shan, et al.
Published: (2017-02-01)